<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="18/07/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8871623" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8871623</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Induction of <term sem="Protein_molecule" id="T1" lex="activator_protein_(AP)-1">activator protein (AP)-1</term> and <term sem="Protein_complex" id="T2" lex="nuclear_factor-kappaB">nuclear factor-kappaB</term> by <term sem="Protein_molecule" id="T3" lex="CD28">CD28</term> stimulation involves both <cons sem="(AND Other Other)" id="C1" lex="(AND phosphatidylinositol_signal acidic_sphongomyelinease_signal)"><frag id="F4"><term sem="Protein_molecule" id="T4" lex="phosphatidylinositol_3-kinase">phosphatidylinositol 3-kinase</term></frag> and <frag id="F5"><term sem="Protein_molecule" id="T6" lex="acidic_sphingomyelinase">acidic sphingomyelinase</term></frag> <frag id="F6">signals</frag></cons>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T3" />
<clue>Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 <clueType>stimulation</clueType> involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="T1" />
<cause idref="E1" />
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> activator protein (AP)-1 and nuclear factor-kappaB <linkCause>by</linkCause> CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="T2" />
<cause idref="E1" />
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> activator protein (AP)-1 and nuclear factor-kappaB <linkCause>by</linkCause> CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="E2" />
<theme idref1="F6" idref="F4" />
<clue>Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation <clueType>involves</clueType> both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E5">
<type class="Correlation" />
<theme idref="E2" />
<theme idref1="F6" idref="T6" />
<clue>Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation <clueType>involves</clueType> both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E6">
<type class="Correlation" />
<theme idref="E3" />
<theme idref1="F6" idref="T4" />
<clue>Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation <clueType>involves</clueType> both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
<event id="E7">
<type class="Correlation" />
<theme idref="E3" />
<theme idref1="F6" idref="T6" />
<clue>Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation <clueType>involves</clueType> both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">A major obstacle in understanding the <term sem="Other" id="T7" lex="signaling_event">signaling events</term> that follow <term sem="Other" id="T8" lex="CD28_receptor_ligation"><term sem="Protein_molecule" id="T9" lex="CD28">CD28</term> receptor ligation</term> arises from the fact that <term sem="Protein_molecule" id="T10" lex="CD28">CD28</term> acts as a costimulus to <term sem="Other" id="T11" lex="TCR_engagement"><term sem="Protein_family_or_group" id="T12" lex="TCR">TCR</term> engagement</term>, making it difficult to assess the relative contribution of <term sem="Other" id="T13" lex="CD28_signal"><term sem="Protein_molecule" id="T14" lex="CD28">CD28</term> signals</term> as distinct from those of the <term sem="Protein_family_or_group" id="T15" lex="TCR">TCR</term>.</sentence>
<event id="E8">
<type class="Binding" />
<theme idref="T12" />
<clue>A major obstacle in understanding the signaling events that follow CD28 receptor ligation arises from the fact that CD28 acts as a costimulus to TCR <clueType>engagement</clueType>, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.</clue>
</event>
<event id="E9">
<type class="Binding" />
<theme idref="T9" />
<clue>A major obstacle in understanding the signaling events that follow CD28 receptor <clueType>ligation</clueType> arises from the fact that CD28 acts as a costimulus to TCR engagement, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T7" />
<cause idref="E9" />
<clue>A major obstacle in understanding the signaling events that <clueType>follow</clueType> CD28 receptor ligation arises from the fact that CD28 acts as a costimulus to TCR engagement, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.</clue>
</event>
<event id="E11">
<type class="Correlation" />
<theme idref="T10" />
<theme idref="E8" />
<clue>A major obstacle in understanding the signaling events that follow CD28 receptor ligation arises from the fact that CD28 <clueType>acts as a costimulus</clueType> <linkTheme>to</linkTheme> TCR engagement, making it difficult to assess the relative contribution of CD28 signals as distinct from those of the TCR.</clue>
</event>
<sentence id="S3">To overcome this problem, we have exploited the observation that <term sem="Cell_natural" id="A3">activated <term sem="Cell_natural" id="T16" lex="human_T_cell_blast">human T cell blasts</term></term> can be stimulated via the <term sem="Protein_molecule" id="T17" lex="CD28_surface_molecule"><term sem="Protein_molecule" id="T18" lex="CD28">CD28</term> surface molecule</term> in the absence of <term sem="Other" id="T19" lex="antigenic_challenge">antigenic challenge</term>; thus, we have been able to observe the response of <term sem="Cell_natural" id="T20" lex="normal_T_cell">normal T cells</term> to <term sem="Protein_molecule" id="T21" lex="CD28">CD28</term> activation in isolation.</sentence>
<event id="E12">
<type class="Physiological_process" />
<theme idref="T16" />
<clue>To overcome this problem, we have exploited the observation that <clueType>activated</clueType> human T cell blasts can be stimulated via the CD28 surface molecule in the absence of antigenic challenge; thus, we have been able to observe the response of normal T cells to CD28 activation in isolation.</clue>
</event>
<event id="E13">
<type class="Physiological_process" />
<theme idref="A3" />
<cause idref="T18" />
<clue>To overcome this problem, we have exploited the observation that activated human T cell blasts can be <clueType>stimulated</clueType> <linkCause>via</linkCause> the CD28 surface molecule in the absence of antigenic challenge; thus, we have been able to observe the response of normal T cells to CD28 activation in isolation.</clue>
</event>
<event assertion="non-exist" id="E14">
<type class="Correlation" />
<theme idref="E13" />
<theme idref="E19" />
<clue>To overcome this problem, we have exploited the observation that activated human T cell blasts can be stimulated via the CD28 surface molecule <clueType>in the absence of</clueType> antigenic challenge; thus, we have been able to observe the response of normal T cells to CD28 activation in isolation.</clue>
<comment>CAUTION</comment>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T21" />
<clue>To overcome this problem, we have exploited the observation that activated human T cell blasts can be stimulated via the CD28 surface molecule in the absence of antigenic challenge; thus, we have been able to observe the response of normal T cells to CD28 <clueType>activation</clueType> in isolation.</clue>
</event>
<event uncertainty="doubtful" id="E16">
<type class="Regulation" />
<theme idref="T20" />
<cause idref="E15" />
<clue>To overcome this problem, we have exploited the observation that activated human T cell blasts can be stimulated via the CD28 surface molecule in the absence of antigenic challenge; thus, we have been able to observe the <clueType>response</clueType> <linkTheme>of</linkTheme> normal T cells to CD28 activation in isolation.</clue>
</event>
<sentence id="S4">Using this system, we observed that <term sem="Other" id="T22" lex="CD28_stimulation"><term sem="Protein_molecule" id="T23" lex="CD28">CD28</term> stimulation</term> by <term sem="Cell_cultured" id="T24" lex="B7-transfected_CHO_cell"><term sem="DNA_domain_or_region" id="A4">B7</term>-transfected <term sem="Cell_cultured" id="A5">CHO cells</term></term> induced a proliferative response in <term sem="Cell_natural" id="T25" lex="T_cell">T cells</term> that was not accompanied by measurable <term sem="Other" id="T26" lex="IL-2_production"><term sem="Protein_molecule" id="T27" lex="IL-2">IL-2</term> production</term>.</sentence>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T23" />
<cause idref="T24" />
<clue>Using this system, we observed that CD28 <clueType>stimulation</clueType> <linkCause>by</linkCause> B7-transfected CHO cells induced a proliferative response in T cells that was not accompanied by measurable IL-2 production.</clue>
</event>
<event id="E18">
<type class="Gene_expression" />
<theme idref="A4" />
<clue>Using this system, we observed that CD28 stimulation by B7-<clueType>transfected</clueType> CHO cells induced a proliferative response in T cells that was not accompanied by measurable IL-2 production.</clue>
</event>
<event id="E180">
<type class="Positive_regulation" />
<theme idref="E18" />
<clue>Using this system, we observed that CD28 stimulation by B7-<clueType>transfected</clueType> <clueLoc>CHO cells</clueLoc> induced a proliferative response in T cells that was not accompanied by measurable IL-2 production.</clue>
</event>
<event id="E19">
<type class="Cellular_physiological_process" />
<theme idref="T25" />
<clue>Using this system, we observed that CD28 stimulation by B7-transfected CHO cells induced a <clueType>proliferative response</clueType> in T cells that was not accompanied by measurable IL-2 production.</clue>
</event>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="E19" />
<cause idref="E17" />
<clue>Using this system, we observed that CD28 stimulation by B7-transfected CHO cells <clueType>induced</clueType> a proliferative response <clueLoc>in T cells</clueLoc> that was not accompanied by measurable IL-2 production.</clue>
</event>
<event id="E21">
<type class="Gene_expression" />
<theme idref="T27" />
<clue>Using this system, we observed that CD28 stimulation by B7-transfected CHO cells induced a proliferative response in T cells that was not accompanied by measurable IL-2 <clueType>production</clueType>.</clue>
</event>
<event assertion="non-exist" id="E22">
<type class="Positive_regulation" />
<theme idref="E21" />
<cause idref="E17" />
<clue>Using this system, we observed that CD28 stimulation by B7-transfected CHO cells induced a proliferative response in T cells that was not <clueType>accompanied</clueType> <linkTheme>by</linkTheme> measurable IL-2 production.</clue>
</event>
<sentence id="S5">However, subsequent analysis of <term sem="Other" id="T28" lex="transcription_factor_generation"><term sem="Protein_family_or_group" id="T29" lex="transcription_factor">transcription factor</term> generation</term> revealed that <term sem="Other" id="T30" lex="B7_stimulation"><term sem="Protein_molecule" id="A6">B7</term> stimulation</term> induced both <term sem="Protein_molecule" id="T31" lex="activator_protein-1">activator protein-1</term> (<term sem="Protein_molecule" id="T32" lex="AP-1">AP-1</term>) and <term sem="Protein_complex" id="T33" lex="nuclear_factor-kappaB_(NF-kappaB)_complex"><term sem="Protein_complex" id="T34" lex="nuclear_factor-kappaB">nuclear factor-kappaB</term> (<term sem="Protein_complex" id="T35" lex="NF-kappaB">NF-kappaB</term>) complexes</term>, but not <term sem="Protein_family_or_group" id="T36" lex="NF-AT">NF-AT</term>.</sentence>
<event id="E23">
<type class="Positive_regulation" />
<cause idref="A6" />
<clue>However, subsequent analysis of transcription factor generation revealed that B7 <clueType>stimulation</clueType> induced both activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) complexes, but not NF-AT.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="E23" />
<clue>However, subsequent analysis of transcription factor generation revealed that B7 stimulation <clueType>induced</clueType> both activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) complexes, but not NF-AT.</clue>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="E23" />
<clue>However, subsequent analysis of transcription factor generation revealed that B7 stimulation <clueType>induced</clueType> both activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) complexes, but not NF-AT.</clue>
</event>
<event assertion="non-exist" id="E26">
<type class="Positive_regulation" />
<theme idref="T36" />
<cause idref="E23" />
<clue>However, subsequent analysis of transcription factor generation revealed that B7 stimulation <clueType>induced</clueType> both activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) complexes, but not NF-AT.</clue>
</event>
<sentence id="S6">In contrast, engagement of the <term sem="Protein_family_or_group" id="T37" lex="TCR">TCR</term> by <term sem="Protein_molecule" id="T38" lex="class_II_MHC/superantigen">class II MHC/superantigen</term>, either with or without <term sem="Protein_molecule" id="T39" lex="CD28">CD28</term> ligation, resulted in the induction of <term sem="Protein_family_or_group" id="T40" lex="NF-AT">NF-AT</term>, <term sem="Protein_molecule" id="T41" lex="AP-1">AP-1</term>, and <term sem="Protein_complex" id="T42" lex="NF-kappaB">NF-kappaB</term> as well as <term sem="Other" id="T43" lex="IL-2_production"><term sem="Protein_molecule" id="T44" lex="IL-2">IL-2</term> production</term>.</sentence>
<event id="E27">
<type class="Binding" />
<theme idref="T37" />
<theme idref="T38" />
<clue>In contrast, <clueType>engagement</clueType> <linkTheme>of</linkTheme> the TCR <linkTheme>by</linkTheme> class II MHC/superantigen, either with or without CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event id="E28">
<type class="Gene_expression" />
<theme idref="T44" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 <clueType>production</clueType>.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="T40" />
<cause idref="E27" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 ligation, resulted in the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T41" />
<cause idref="E27" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 ligation, resulted in the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="T42" />
<cause idref="E27" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 ligation, resulted in the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="E28" />
<cause idref="E27" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 ligation, resulted in the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event id="E33">
<type class="Binding" />
<theme idref="T39" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either with or without CD28 <clueType>ligation</clueType>, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
</event>
<event assertion="non-exist" id="E34">
<type class="Correlation" />
<theme idref="E33" />
<theme idref="E29" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either <clueType>with or without</clueType> CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
<comment>CAUTION: cluetype</comment>
</event>
<event assertion="non-exist" id="E35">
<type class="Correlation" />
<theme idref="E33" />
<theme idref="E30" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either <clueType>with or without</clueType> CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
<comment>CAUTION: cluetype</comment>
</event>
<event assertion="non-exist" id="E36">
<type class="Correlation" />
<theme idref="E33" />
<theme idref="E31" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either <clueType>with or without</clueType> CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
<comment>CAUTION: cluetype</comment>
</event>
<event assertion="non-exist" id="E37">
<type class="Correlation" />
<theme idref="E33" />
<theme idref="E32" />
<clue>In contrast, engagement of the TCR by class II MHC/superantigen, either <clueType>with or without</clueType> CD28 ligation, resulted in the induction of NF-AT, AP-1, and NF-kappaB as well as IL-2 production.</clue>
<comment>CAUTION: cluetype</comment>
</event>
<sentence id="S7">Using <term sem="Other" id="T45" lex="selective_inhibitor">selective inhibitors</term>, we investigated the <term sem="Other" id="T46" lex="signaling_pathway">signaling pathways</term> involved in the <term sem="Other" id="T47" lex="CD28-mediated_induction"><term sem="Protein_molecule" id="T48" lex="CD28">CD28</term>-mediated induction</term> of <term sem="Protein_molecule" id="T49" lex="AP-1">AP-1</term> and <term sem="Protein_complex" id="T50" lex="NF-kappaB">NF-kappaB</term>.</sentence>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="T49" />
<cause idref="T48" />
<clue>Using selective inhibitors, we investigated the signaling pathways involved in the CD28-<linkCause>mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> AP-1 and NF-kappaB.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="T50" />
<cause idref="T48" />
<clue>Using selective inhibitors, we investigated the signaling pathways involved in the CD28-<linkCause>mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> AP-1 and NF-kappaB.</clue>
</event>
<event uncertainty="doubtful" id="E40">
<type class="Correlation" />
<theme idref="E38" />
<theme idref="T46" />
<clue><clueExperiment>Using selective inhibitors</clueExperiment>, we investigated the signaling pathways <clueType>involved</clueType> <linkTheme>in</linkTheme> the CD28-mediated induction of AP-1 and NF-kappaB.</clue>
</event>
<event uncertainty="doubtful" id="E41">
<type class="Correlation" />
<theme idref="E39" />
<theme idref="T46" />
<clue><clueExperiment>Using selective inhibitors</clueExperiment>, we investigated the signaling pathways <clueType>involved</clueType> <linkTheme>in</linkTheme> the CD28-mediated induction of AP-1 and NF-kappaB.</clue>
</event>
<sentence id="S8">This revealed that <term sem="Other" id="T51" lex="NF-kappaB_generation"><term sem="Protein_complex" id="T52" lex="NF-kappaB">NF-kappaB</term> generation</term> was sensitive to <term sem="Organic_compound_other" id="A7">chloroquine</term>, an inhibitor of <term sem="Protein_molecule" id="T53" lex="acidic_sphingomyelinase">acidic sphingomyelinase</term>, but not to the <term sem="Organic_compound_other" id="T54" lex="phosphatidylinositol_3-kinase_inhibitor"><term sem="Protein_molecule" id="T55" lex="phosphatidylinositol_3-kinase">phosphatidylinositol 3-kinase</term> inhibitor</term>, <term sem="Organic_compound_other" id="T56" lex="wortmannin">wortmannin</term>.</sentence>
<event id="E42">
<type class="Gene_expression" />
<theme idref="T52" />
<clue>This revealed that NF-kappaB <clueType>generation</clueType> was sensitive to chloroquine, an inhibitor of acidic sphingomyelinase, but not to the phosphatidylinositol 3-kinase inhibitor, wortmannin.</clue>
</event>
<event id="E43">
<type />
<theme idref="E42" />
<cause idref="A7" />
<clue>This revealed that NF-kappaB generation was <clueType>sensitive</clueType> <linkCause>to</linkCause> chloroquine, an inhibitor of acidic sphingomyelinase, but not to the phosphatidylinositol 3-kinase inhibitor, wortmannin.</clue>
<comment>SENSITIVITY</comment>
</event>
<event assertion="non-exist" id="E44">
<type />
<theme idref="E42" />
<cause idref="T56" />
<clue>This revealed that NF-kappaB generation was <clueType>sensitive</clueType> to chloroquine, an inhibitor of acidic sphingomyelinase, but not <linkCause>to</linkCause> the phosphatidylinositol 3-kinase inhibitor, wortmannin.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E45">
<type class="Negative_regulation" />
<theme idref="T53" />
<cause idref="A7" />
<clue>This revealed that NF-kappaB generation was sensitive to chloroquine, an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> acidic sphingomyelinase, but not to the phosphatidylinositol 3-kinase inhibitor, wortmannin.</clue>
</event>
<event id="E46">
<type class="Negative_regulation" />
<theme idref="T55" />
<cause idref="T56" />
<clue>This revealed that NF-kappaB generation was sensitive to chloroquine, an inhibitor of acidic sphingomyelinase, but not to the phosphatidylinositol 3-kinase <clueType>inhibitor</clueType>, wortmannin.</clue>
</event>
<sentence id="S9">In contrast, <term sem="Protein_molecule" id="T57" lex="AP-1">AP-1</term> generation was inhibited by <term sem="Organic_compound_other" id="T58" lex="wortmannin">wortmannin</term> and was also variably sensitive to <term sem="Organic_compound_other" id="T59" lex="chloroquine">chloroquine</term>.</sentence>
<event id="E47">
<type class="Gene_expression" />
<theme idref="T57" />
<clue>In contrast, AP-1 <clueType>generation</clueType> was inhibited by wortmannin and was also variably sensitive to chloroquine.</clue>
</event>
<event id="E48">
<type class="Negative_regulation" />
<theme idref="E47" />
<cause idref="T58" />
<clue>In contrast, AP-1 generation was <clueType>inhibited</clueType> <linkCause>by</linkCause> wortmannin and was also variably sensitive to chloroquine.</clue>
</event>
<event id="E49">
<type />
<theme idref="E47" />
<cause idref="T59" />
<clue>In contrast, AP-1 generation was inhibited by wortmannin and was also variably <clueType>sensitive</clueType> <linkCause>to</linkCause> chloroquine.</clue>
<comment>SENSITIVITY</comment>
</event>
<sentence id="S10">These data suggest that in activated <term sem="Cell_natural" id="T60" lex="normal_T_cell">normal T cells</term>, <term sem="Other" id="T61" lex="CD28-derived_signal"><term sem="Protein_molecule" id="T62" lex="CD28">CD28</term>-derived signals</term> can stimulate proliferation at least in part via <cons sem="(AND Other Other)" id="T63" lex="(AND NF-kappaB_generation AP-1_generation)"><frag id="F1"><term sem="Protein_complex" id="A8">NF-kappaB</term></frag> and <frag id="F2"><term sem="Protein_complex" id="A9">AP-1</term></frag> <frag id="F3">generation</frag></cons>, and that this response uses both <term sem="Protein_molecule" id="T64" lex="acidic_sphingomyelinase">acidic sphingomyelinase</term> and <term sem="Other" id="T65" lex="phosphatidylinositol_3-kinase-linked_pathway"><term sem="Protein_molecule" id="T66" lex="phosphatidylinositol_3-kinase">phosphatidylinositol 3-kinase</term>-<term sem="Other" id="A10">linked pathways</term></term>.</sentence>
<event id="E50">
<type class="Physiological_process" />
<theme idref="T60" />
<clue>These data suggest that in <clueType>activated</clueType> normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event id="E51">
<type class="Cellular_physiological_process" />
<theme idref="T60" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate <clueType>proliferation</clueType> at least in part via NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event id="E52">
<type class="Gene_expression" />
<theme idref="A8" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 <clueType>generation</clueType>, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event id="E53">
<type class="Gene_expression" />
<theme idref="A9" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 <clueType>generation</clueType>, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event id="E54">
<type class="Positive_regulation" />
<theme idref="E52" />
<cause idref="T61" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can <clueType>stimulate</clueType> proliferation at least in part via NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event id="E55">
<type class="Positive_regulation" />
<theme idref="E53" />
<cause idref="T61" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can <clueType>stimulate</clueType> proliferation at least in part via NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event uncertainty="probable" id="E56">
<type class="Positive_regulation" />
<theme idref="E51" />
<cause idref="E54" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can <clueType>stimulate</clueType> proliferation at least in part <linkCause>via</linkCause> NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event uncertainty="probable" id="E57">
<type class="Positive_regulation" />
<theme idref="E51" />
<cause idref="E55" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can <clueType>stimulate</clueType> proliferation at least in part <linkCause>via</linkCause> NF-kappaB and AP-1 generation, and that this response uses both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event uncertainty="probable" id="E58">
<type class="Positive_regulation" />
<theme idref="E56" />
<cause idref1="A10" idref="T64" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 generation, and that this response <clueType>uses</clueType> both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
<comment>NER: T64 MOD</comment>
</event>
<event uncertainty="probable" id="E59">
<type class="Positive_regulation" />
<theme idref="E56" />
<cause idref1="A10" idref="T66" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 generation, and that this response <clueType>uses</clueType> both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
<comment>NER: T66 MOD</comment>
</event>
<event uncertainty="probable" id="E60">
<type class="Positive_regulation" />
<theme idref="E57" />
<cause idref1="A10" idref="T64" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 generation, and that this response <clueType>uses</clueType> both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
<event uncertainty="probable" id="E61">
<type class="Positive_regulation" />
<theme idref="E57" />
<cause idref1="A10" idref="T66" />
<clue>These data suggest that in activated normal T cells, CD28-derived signals can stimulate proliferation at least in part via NF-kappaB and AP-1 generation, and that this response <clueType>uses</clueType> both acidic sphingomyelinase and phosphatidylinositol 3-kinase-linked pathways.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
